John Nosenzo, Chief Commercial Officer at Bioventus Inc. (BVS), bought 500 shares at $13.00 ($7K) on 2021-02-11, disclosed to the SEC on 2021-04-05.
Open-market purchase of $6k BVS by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BVS | SELL | 2022-02-15 | $6K | — | Filing → |